WIC
BMY icon

Whitegate Investment Counselors’s Bristol-Myers Squibb BMY Stock Holding History

Whitegate Investment Counselors’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-11,799
Closed -$698K – 78
2021
Q3 		$698K Sell
11,799
-317
-3% -$20.9K 0.1% 138
2021
Q2 		$810K Buy
12,116
+9
+0.1% +$587 0.11% 134
2021
Q1 		$764K Buy
12,107
+8
+0.1% +$498 0.12% 130
2020
Q4 		$750K Buy
12,099
+1,489
+14% +$91.6K 0.12% 126
2020
Q3 		$640K Buy
10,610
+8
+0.1% +$481 0.12% 125
2020
Q2 		$623K Buy
10,602
+8
+0.1% +$479 0.12% 124
2020
Q1 		$590K Buy
10,594
+191
+2% +$11.7K 0.14% 117
2019
Q4 		$668K Buy
10,403
+848
+9% +$48.6K 0.12% 132
2019
Q3 		$485K Buy
9,555
+220
+2% +$10.3K 0.1% 139
2019
Q2 		$423K Sell
9,335
-318
-3% -$14.8K 0.09% 139
2019
Q1 		$461K Buy
9,653
+388
+4% +$19.3K 0.1% 136
2018
Q4 		$482K Buy
9,265
+2
+0% +$107 0.11% 131
2018
Q3 		$575K Sell
9,263
-598
-6% -$35.5K 0.12% 125
2018
Q2 		$546K Buy
9,861
+2
+0% +$108 0.11% 124
2018
Q1 		$624K Buy
9,859
+168
+2% +$10.8K 0.13% 118
2017
Q4 		$594K Buy
9,691
+45
+0.5% +$2.81K 0.12% 123
2017
Q3 		$615K Hold
9,646
– – 0.14% 119
2017
Q2 		$537K Sell
9,646
-300
-3% -$16.3K 0.12% 121
2017
Q1 		$541K Sell
9,946
-58
-0.6% -$3.18K 0.13% 118
2016
Q4 		$585K Sell
10,004
-400
-4% -$21.9K 0.16% 105
2016
Q3 		$561K Sell
10,404
-125
-1% -$8.03K 0.15% 105
2016
Q2 		$774K Buy
+10,529
New +$744K 0.21% 96
2014
Q1 		$615K Buy
+9,629
New +$512K 0.17% 102

Other funds holding BMY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Whitegate Investment Counselors's BMY Position: Q4 2021 in Review

Whitegate Investment Counselors sold out of Bristol-Myers Squibb (BMY) in Q4 2021, closing a stake of 11,799 shares — an estimated $698K sold.

Whitegate Investment Counselors first reported a position in BMY in Q1 2014 and held it in 23 quarters. The position peaked at $810K in Q2 2021. 2,444 funds tracked by Wall St. Rank hold BMY as of Q4 2021.

  • Whitegate Investment Counselors reported no remaining Bristol-Myers Squibb position as of Q4 2021 after selling out during the quarter.
  • Whitegate Investment Counselors sold 11,799 Bristol-Myers Squibb shares in Q4 2021, an estimated $698K.
  • Whitegate Investment Counselors first reported a position in Bristol-Myers Squibb in Q1 2014 and held it in 23 quarters.
  • Whitegate Investment Counselors's Bristol-Myers Squibb position peaked at $810K in Q2 2021.
  • 2,444 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2021.

Based on Whitegate Investment Counselors's 13F filing for Q4 2021, filed 3 Feb 2022.